Aspirin or P2Y12i monotherapy for secondary prevention in patients with CAD?
This video was recorded during the ESC Congress 2022 in Barcelona, Spain.
Marco Valgimigli, MD, PhD - Cardiocentro Ticino Foundation, Lugano in Switzerland.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.